Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Deciphera Pharmaceuticals (DCPH) is now available.
Following the merger on June 11, 2024, Deciphera has made significant changes including the termination of various equity and stock plans, the resignation of several board members, and the appointment of new ones. Additionally, the company has amended its certificate of incorporation and by-laws, notified Nasdaq to suspend trading, and intends to cease its reporting obligations. Furthermore, Deciphera has canceled its upcoming Annual Meeting of Stockholders originally scheduled for June 20, 2024.
See more data about DCPH stock on TipRanks’ Stock Analysis page.